Dark

ATOS
Atossa Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jul 25, 2025 3:59:30 PM EDT

0.8292USD-3.794%(-0.0327)1,188,546

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jul 25, 2025 9:21:30 AM EDT

0.8624USD+0.058%(+0.0005)468

After-hours

Jul 24, 2025 4:20:30 PM EDT

0.8650USD+0.581%(+0.0050)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

108.88M

CEO

Steven Quay

Headquarters

Seattle, Washington, USA

Industry

Biotechnology

Next Earnings

Aug 18, 2025 (22d)

Last Split

Apr 20, 20181for12reverse

XLV

ATOS Stats

Avg. Vol. 10 Day

653,812

Avg. Vol. 30 Day

1,240,935

Market Cap

108,877,396

Shares Out.

129,170,004

On/Off Exchange

50%/50%

6 Month Beta

1.08

1 Year Beta

1.27

2 Year Beta

1.29

3 Year Beta

1.03

52 Week Low

0.55

52 Week High

1.66

SMA50

0.87

SMA200

0.96

1 Week

-0.68%

1 Month

-4.16%

3 Month

+13.48%

6 Month

-3.37%

1 Year

-42.66%

2 Year

-18.95%

5 Year

-78.39%

Profile

atossa therapeutics, inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the united states. the company's lead program is the development of endoxifen, an active metabolite of tamoxifen which is in phase ii studies to treat and prevent breast cancer. it is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and chimeric antigen receptor t-cell therapies, directly to the site of breast cancer. the company was formerly known as atossa genetics inc. and changed its name to atossa therapeutics, inc. in january 2020. atossa therapeutics, inc. was founded in 2009 and is headquartered in seattle, washington.

ATOS Stock Summary

Atossa Therapeutics, Inc. Common Stock (NASDAQ:ATOS) stock price today is $0.8292, and today's volume is 1,188,546. ATOS is down -3.794% today. The 30 day average volume is 1,240,935. ATOS market cap is 108.88M with 129,170,004 shares outstanding.